Katherine Dyer, PA
Surgical · Charlotte, NCNPI 1417363623
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,676 of the $1,876 with a category attached, or 89.3%. 21 manufacturers reported payments, led by Astellas Pharma US Inc at 26.8% of the total. Reporting peaked in 2023 at $1,212 and has fallen 91.5% since, to $103 in 2025.
Across 73 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$502
- Sumitomo Pharma America, Inc.$223
- Convatec Inc.$189
- Endo Pharmaceuticals Inc.$164
- Procept Biorobotics Corporation$148
- Urogen Pharma, Inc.$136
- plus $514 from 15 others
What the payments were for
- Food & beverage$1,67689%
- Education$20011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $502 |
| Sumitomo Pharma America, Inc. | 12 | $223 |
| Convatec Inc. | 6 | $189 |
| Endo Pharmaceuticals Inc. | 10 | $164 |
| Procept Biorobotics Corporation | 1 | $148 |
| Urogen Pharma, Inc. | 5 | $136 |
| Medical Device Business Services, Inc. | 1 | $83 |
| Progenics Pharmaceuticals, Inc. | 3 | $67 |
| Boston Scientific | 2 | $48 |
| Pfizer | 2 | $40 |
| Accord Healthcare, Inc. | 2 | $40 |
| Merck | 2 | $40 |
| Blue Earth Diagnostics | 2 | $32 |
| Olympus America Inc. | 1 | $27 |
| Teleflex LLC | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Smith+Nephew | 1 | $19 |
| 180 Medical, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| ABC Home Medical Supply, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,876 in reported general payments places this provider in the 85th percentile of 248 surgical providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 61 | $51,441 |
| MyrbetriqMirabegron | 44 | $20,920 |
| ElmironPentosan Polysulfate Sodium | 12 | $14,156 |
| Tamsulosin Hcl | 208 | $2,043 |
| Finasteride | 162 | $1,963 |
| Estradiol | 12 | $608 |
| Methenamine Hippurate | 13 | $572 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $411 |
| Ciprofloxacin Hcl | 33 | $373 |
| Oxybutynin Chloride | 17 | $326 |
| Cephalexin | 25 | $318 |
| Oxybutynin Chloride ErOxybutynin Chloride | 36 | $245 |
| Testosterone Cypionate | 12 | $190 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $157 |
| Oxycodone Hcl | 26 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $223 | $51,44161 claims |
| Astellas Pharma US IncMyrbetriq | $502 | $20,92044 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 248 surgical providers in North Carolina.
Other surgical in Charlotte
- Jennifer CokerCharlotte$2K
- Michael McCormickCharlotte$2K
- Justin BrooksCharlotte$2K
- Tina FiorettiCharlotte$2K
- Mackenzie SteenCharlotte$1K
- Brandon GriffinCharlotte$1K
- Kevan HaasChapel Hill$44K
- Lawrence LandriganWilmington$12K
- Erika LynchLeland$10K
- Sheila AndersonWilmington$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.